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Abstract: Transmission intensity of a thin tissue sample produce intensity distribution that is 
proportional to the refractive index pattern in the thin slice, in turn reflects mass density pattern, and using 
the intensity pattern, fractal dimension can be calculated. In this paper, we report fractal dimension 
analyses of MUC13 stained pancreatic cancer tissues. Pancreatic cancer is deadliest due to its physical 
orientation, and no prominent chemical change till the late stages of cancer. The presence of pancreatic 
cancer can be detected using MUC13 dye, however this fails to explain about the stages of cancer. Here 
we studied MUC13 expressed cancer tissues and observe their cancer stages by fractal dimension of light 
transmission intensity. Our results show that early stages of pancreatic cancer for MUC13 expressed 
tissue was accurately distinguished by fractal dimension analysis. Further, its applications to cancer 
diagnostics is also discussed in detail.   
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1. INTRODUCTION  
Progression of cancer in tissues and fractal dimension: A tissue is a fractal object due to its 
immanent self-similar patterns from larger to decreasingly smaller length scales. With the 
progression of cancer in the tissues, the tissue structure changes which in turn alter the fractality 
and hence increased in the fractal dimension. As a cancer progresses in tissue, cells inside the 
tissue changes coherently and they multiply rapidly in asymmetrical pattern resulting to have 
systematic change in fractal dimensions. This implies a strong correlation between the change in 
fractal dimension and the progression of cancer. 
Optical transmission intensity of thin tissue samples and fractal dimension detection for 
cancer. Optical transmission intensity of thin tissue samples can produce intensity distribution 
that is proportional to the refractive index pattern in the thin tissue slices, in turn mass density 
pattern. Using these intensity patterns, mean fractal dimension can be calculated.  
Pancreatic cancer and its difficulties in detection: The American Cancer Society has 
reported that in 2018 about 55,440 people will be diagnosed with pancreatic cancer and about 
44,330 people will die of pancreatic cancer in the United States. About 3% of all cancers in the 
US and about 7% of all cancer deaths are reported for pancreatic cancer. Since pancreas is an 
organ located deep in the stomach i.e. on the right side of abdomen and is connected to the 
duodenum, it is difficult to diagnose the tumor by physician during routine examination due to its 
inaccessibility. People with pancreatic cancer develop no symptoms and chemical change even 
in later stages of cancer. Therefore, accurate detection and staging are important for pancreatic 
cancer diagnostics and treatments.  
The state-of-the-art can detect stages and classify pancreatic cancer through the utilization of 
fractal dimensional analysis. In this work, the correlation between fractal dimension and 
pancreatic cancer staging related to MUC13 expressed pancreatic tissue microarray (TMA) 
samples are reported. The results clarify the pancreatic cancer growth by MUC13 expression in 
cancerous tissue, and their correlation to fractal dimension.  
 
1.1 Detection of Pancreatic Cancer 
    Pancreatic cancer remains as a major unresolved health problem in this present medical era. 
As mentioned earlier, American Cancer Society reports that in 2018, pancreatic cancer is about 
3% of the total cancers and about 7% of all the cancer deaths in the US. Pancreatic cancer has the 
worst 5 years survival rate of all the common cancers (Allemani et al., 2018). Since pancreas is 
deep-seated within the abdomen and pancreatic cancer can spread out from initial to later stages 
shortly (less than 2 years), it is very critical and important to develop early detection methods. 
The ongoing histological processes for the detection of cancer are inefficient for the pancreatic 
cancer detection. Many times, the pathological tests are inconclusive although the patients may 
have pancreatic cancer symptoms. Very few cases of pancreatic cancer are diagnosed when it is 
within pancreas, but without tumors. It, therefore, demands for a development of effective 
diagnostic tool for the early detection of the pancreatic cancer. 
 
1.2 Pancreatic Cancer and MUC13  
Pancreatic cancer is considered as deadliest due to the lack of reliable early detection methods 
and underlying mechanisms of its aggressive pathogenesis. Recent studies have shown a newly 
identified transmembrane mucin, MUC13 plays important role in the diagnostic and therapeutic 
of pancreatic cancer. MUC13 is a cell surface glycoprotein acts as lubricant and chemical 
barriers in the cell membrane.  The expression profile of MUC13 was found highly significant in 
cancerous samples compare with normal pancreatic tissues. Therefore, the biomarker MUC13 
expressed significantly in pancreatic cancer leaving red sport resulting in higher mass 
accumulation.   
1.3 Fractal Dimension and quantification 
    The development of techniques for the detection of the cancerous cells/tissues is a major 
challenge in the healthcare industry. However;  fractal dimensional analysis can be taken as one 
of the methods that can overcome this challenge (de Arruda et al., 2013; Gazit, Berk, Leunig, 
Baxter, & Jain, 1995; Klatt et al., 2014; Landini & Rippin, 1993; Luzi et al., 1999; Metze, 2013; 
Sankar & Thomas, 2010; Stępień & Stępień, 2010). Fractal dimension analysis essentially serves 
as a morphometric measure of irregular structures in biological samples, such as those 
predominantly found in tissues as well as its progression with cancer. It has been reported that 
the progress of cancer makes tissue more chaotic than the normal tissues (Nagy, Chang, Dvorak, 
& Dvorak, 2009). Therefore, fractal dimension analysis can act as a tissue diagnostic tool for 
progressive carcinogenesis. Fractal dimension is a measure of the space-filling capacity of a 
certain pattern in a designated area, some way porosity of the intensity.  
We propose that it is possible to distinguish different stages of pancreatic cancer with the 
aid of this fractal dimension approach. The experimental study clearly indicates the relationship 
between a pancreatic cancer cell stage and its fractal dimension. To elaborate, we found 
variations in the fractal dimension in the two different stages of pancreatic cancer, that is in 
correlation with the stages of cancer.  The aim of this research is to develop a precise method for 
the early detection of pancreatic cancer cells and stages that will help the medical community to 
downplay the cancer patients in future. This method may work independently or help in assisting 
the pathologist.  
 
2. METHOD 
 2.1. Fractal Dimension Calculations  
  Box-counting methods:  Fractal dimension is a mathematical parameter that exhibits self-similar patterns 
at different length scales.  The fractal structure is assumed to be lying on an evenly spaced grid, and 
the number of boxes required to cover the fractal structure are counted. In this method, MUC13 
dye is added to cancerous tissue then fractal dimension is calculated by observing how the 
number changes as the grid is refined by applying a box counting algorithm. Therefore, fractal 
dimension is the measure of space filling capacity of the pattern with the addition of MUC13 
stain in cancerous cell (Bhandari, Choudannavar, Avery, Sahay, & Pradhan, 2018). The fractal 
dimension of the systems follows the scaling power law      , where    being the fractal 
dimension, and is taken easily enough by the popularized Minkowski–Bouligand dimension, or box 
counting method, following if an N-dimensional space containing a specific fractal structure is partitioned 
with a number of N-cubes [N(r)] with side length r, then the N-cube counting fractal dimension is defined 
as  (Dubuc, Quiniou, Roques-Carmes, Tricot, & Zucker, 1989; Mandelbrot, 1982):  
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Counting the number of N-cube of different size (r), the fractal dimension of equation (4) can be 
estimated by the slope of the linear fit of [ln (1/r), ln N(r)].  The N-cube sizes were simulated by powers 
of two with side length r = 1, 2, 4… 2W, where W is the smallest integer such that the length size of the 
system matrix L is less than or equal to 2
W
. The fractal dimension box counting was calculated by the 
open source image based NIH software Image J.  
  2.2.  Pancreatic cancer TMA tissue samples and transmission microscopy image collection 
    A pancreatic cancer tissue micro array sample TMA (PA241b), ordered from Biomax, has two 
different stages of pancreatic cancer tissue types. In our study, we used mainly following three 
categories of pancreatic tissues: stage 1, stage 2 and malignant tumor. The tissue samples were 
stained with MUC13 stain to see the presence of pancreatic cancer. Therefore, MUC13 dye is 
stained with pancreatic cancer tissue in detecting and distinguishing the highly affected cancer 
areas from the unaffected areas. The tissue microarray TMA consists of pancreatic cancer 
samples with MUC13 stain in the array with diameter 1.5mm for each sample and thickness 
5µm. Among all the samples of different stages a total of nine samples i.e. three from each 
cancer stages as mentioned earlier were considered for imaging. The TMA of pancreatic cancer 
stained with MUC13 was kept on the sample holding platform of the microscope operating in 
transmission mode to obtain the optical image. The microscopic images of these samples were 
captured by Olympus BX50 Microscope (Olympus, USA) and an Infinity2 Microscopy Camera 
(Lumenera Corp. Canada) attached to the microscope head. Using Lumenera CAPTURE 
software images at magnification ×40 were sampled and digitized to eight bits of gray level and 
stored as digital files. Ten set of images for all the regions of the stages of cancer were taken as 
new data sets to work with. The affected and unaffected regions are distinguished in terms of 
MUC13 dye expressed in the cells. The regions where the MUC13 dye was expressed were 
termed as affected regions and unexpressed were termed as unaffected regions. That means 
MUC13 expression in the tissue indicates the cancerous tissue and results in the higher spatial 
mass density variation in sample. This mass density variation is linearly related to the 
transmission intensity in the refractive index in the image. Therefore, fractal dimension of the 
optical intensity patterns correlates with the mass density pattern. 
  2.3. Fractal analysis from image data 
    The collected images of the samples were processed by ImageJ (NIH, USA) software and 
analyzed for the fractal dimensions. The fractal dimension analysis tool in ImageJ calculated the 
fractal dimension of each samples, that uses the box counting method. Fractal dimension was 
calculated for unaffected regions, and affected regions of pancreatic cancer stages. In addition, 
the average fractal dimension of the overall cell containing both the regions was also calculated 
for comparisons. The data were organized and processed to calculate the variation in fractal 
dimension of the different stages of pancreatic cancer along with the net standard deviations and 
the p-values. 
 
 3. RESULTS 
 
     The fractal dimension of all the stages of pancreatic cancer samples were calculated using box 
counting method. The observed microscopic images were processed using imageJ fractal 
analysis tool. The captured images of MUC13 unexpressed, average expressed, and expressed 
regions of stages of pancreatic cancer tissues are shown in Figure 1.  
    The experiment shows MUC13 dye on pancreatic cancer tissue interact with cancer affected 
region and remains isolated for normal region. Therefore, in the cancer affected tissue MUC13 
dye can express differently in the different region of the pancreatic tissue. The cell or tissue 
expressed with MUC13 remains as red spot with high mass density fillings, whereas MUC13 
unexpressed region has less mass density fillings.  
 
 
 
 
 
 
 
    
 
 
 
 
Figure 1: Different Stages of pancreatic cancer stained with MUC13 stain. The first row of 
images (a-b) represents MUC13 unexpressed images (optical micrographs), middle row of 
images (a’-b’) represents average MUC13 stained images, and bottom row of images (a’’-b’’) 
represents MUC13 expressed images of stages of pancreatic cancer respectively.   
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MUC13 expressed differently in cancer tissue due to this reason, average fractal dimension of 
the same cancer affected samples were calculated.  Fractal dimension was calculated for stages 
of cancer at three different regions, and an ensemble averaging were performed (over 10 tissues 
per case). In Figure 2, we presented the bar graph for the fractal dimensions of different cancer 
stages. As seen, the fractal dimension has a monotonic behavior i.e. saturation for the different 
stages of the pancreatic cancer that are expressed with the MUC13 dye. In particular, regions 
with MUC13 unexpressed to MUC13 expressed regions of the samples are shown in Figure 1.  
In the bar graphs, the stage 1 pancreatic cancer tissue has the lowest fractal dimension in all the 
three regions of cancer than the stage 2. The fractal dimension of the region of the cells 
unaffected by MUC13 dye increases from stage 1 to stage 2 significantly. Therefore, the average 
fractal dimension of the cell increases the same way. However, the fractal dimension in case of 
Figure 2: Expression of MUC13 stain in different stages of Pancreatic cancer bar graphs: This 
graph shows the distribution of fractal dimension in different stages of pancreatic cancer stained 
with MUC13 stain. The fractal dimension of the areas expressed with MUC13 is greater than that 
of unexpressed by MUC13 stain. The average fractal dimension of the cell is also shown which is 
in between the expressed and the unexpressed areas’ values. This trend is similar in both the stages 
of the pancreatic cancer stained with MUC13 (P-values <0.05). 
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MUC13 expressed region is not significant and remains almost saturated in both the stages of 
cancer. The absolute fractal dimension value of the stage 1 and stage 2 cancer for the MUC13 
unexpressed regions in the tissues were calculated to be 1.53515, and 1.6397, average expressed 
regions to be 1.73415, and 1.74615, and expressed regions to be 1.88838, and 1.85105, 
respectively. These numerical parameters are the logical finding of MUC13 average expressed 
regions as a strong indicator of detection of early stages of pancreatic cancer for all the regions 
of observation. The unique and useful aspect of the approach demonstrated MUC13 stain 
expressed with cancer affected tissues resulting in logical finding of the progress of cancer which 
is due to more mass accumulation with more space filling in tissue, as mentioned. In particular, 
this work concluded fractal dimension of TMA samples is the tool to measure the space 
filling/irregularity of the cell structure that increases as the number of cancerous cells increases. 
 
4. CONCLUSIONS AND DISCUSSIONS  
    This state-of-the-art experiment demonstrated structural properties of pancreatic cancer tissue 
TMA samples in the presence of MUC13 dye, using transmission microscopy micrographs. As a 
preliminary result, fractal dimension of different stages of pancreatic cancer were calculated 
using ImageJ software. The numeric index i.e. fractal dimension increases from a normal to a 
cancerous tissue due to the accumulation of mass density filling with the growth of cancer. 
Further, the presence of MUC13 stain increases the mass filling of the cancerous cells and hence 
the fractal dimension increases. And since, MUC13 gets expressed evenly in cancer affected 
region, the fractal dimension of two different stages of cancer is almost saturated which may not 
be a perfect indicator of stages of cancer detection. The hierarchy of average value of fractal 
dimension of MUC13 expressed samples follow stage 1 < stage 2 and is quite significant (higher 
p-values) than any other regions. Interestingly, the fractal dimension value of MUC13 
unexpressed area has the prominent difference. Therefore, MUC13 expressed average cell fractal 
dimension act as a numeric indicator of stages of pancreatic cancer detection which needs to be 
explored further.  
In Summary, fractal dimension lays foundation for reliable, cost-efficient, easy, and early 
detection of the pancreatic cancer in future medical world. With this capability, fractal 
dimension, a purely mathematical too, distinguishes the stages of cancer avoiding the limitations 
of conventional methods which are highly prone to human error, misguiding, risky, and 
expensive. Moreover, cancerous tissue with biomarker MUC13 dye was found to more efficient 
for cancer detection. With further research and clinical study, fractal dimension analysis method 
can be developed as a reliable diagnostic tool of stages of different cancer diagnosis and can be 
set as guideline 
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